A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

A total of 53 women with chemotherapy-naïve stage Ic-IV ovarian cancer were treated with four cycles of carboplatin area under the curve 7 every 3 weeks, followed by four cycles of paclitaxel 70 mg m(−2) (days 1, 8, and 15) and gemcitabine 1000 mg m(−2) (days 1 and 8) every 3 weeks. In all, 37 (70%)...

Descripción completa

Detalles Bibliográficos
Autores principales: Harries, M, Moss, C, Perren, T, Gore, M, Hall, G, Everard, M, A'Hern, R, Gibbens, I, Jenkins, A, Shah, R, Cole, C, Pizzada, O, Kaye, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364776/
https://www.ncbi.nlm.nih.gov/pubmed/15238984
http://dx.doi.org/10.1038/sj.bjc.6602000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364776/
https://www.ncbi.nlm.nih.gov/pubmed/15238984
http://dx.doi.org/10.1038/sj.bjc.6602000

Ejemplares similares